Harsh Bhavsar

Statistics

Publications

Citations

150

H-Index

Active since

2019

Affiliations

Zydus Lifesciences Limited (India)(Current)

Harsh Bhavsar is an author at Zydus Lifesciences Limited (India) specializing in life sciences, inflammasome inhibition mechanisms, and innate immunity.

Publications per year

2019–2024

Publications

<i>Piezo1</i> regulates cholesterol biosynthesis to influence neural stem cell fate during brain development

Jamison L. Nourse, Vivian M. Leung, Hamid Abuwarda et al. · The Journal of General Physiology · 2022 · 53 citations · Full text

Life Sciences, Developmental Biology, Neuroscience +17

Discovery of <i>N</i>-Cyano-sulfoximineurea Derivatives as Potent and Orally Bioavailable NLRP3 Inflammasome Inhibitors

Sameer Agarwal, Santosh Sasane, Hardik Shah et al. · ACS Medicinal Chemistry Letters · 2020 · 49 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +13

Identification of a novel orally bioavailable NLRP3 inflammasome inhibitor

Sameer Agarwal, Jignesh P. Pethani, Hardik Shah et al. · Bioorganic & Medicinal Chemistry Letters · 2020 · 22 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +11

Early Detection of Cardiac Disease Using Machine Learning

Paras Chavda, Harsh Bhavsar, Yash Pithadia et al. · SSRN Electronic Journal · 2019 · 13 citations · Full text

Computing, Cardiology, Health Informatics +15

A novel selective NLRP3 inhibitor shows disease-modifying potential in animal models of Parkinson’s disease

Abhijit Chatterjee, Jogeswar Mohapatra, Manoranjan Sharma et al. · Brain Research · 2024 · 13 citations

Life Sciences, Neuroscience, Pharmacology +15

1–5 of 5